A critical time intervention with mentally ill homeless men: impact on psychiatric symptoms.

We describe the impact of a psychosocial intervention, critical time intervention (CTI), on the cardinal symptom dimensions of schizophrenia, namely negative, positive, and general psychopathology. Ninety-six men with schizophrenia and other psychotic disorders who were discharged from a homeless shelter were randomly assigned to receive either CTI or usual services only. CTI is a time-limited intervention designed to enhance continuity of care during the transition from institution to community. Symptom severity at baseline and at 6 months was assessed using the Positive and Negative Syndrome Scale. Using data on 76 subjects for whom we have complete symptom data, we assessed the impact of CTI on change in symptoms. The results suggest that CTI was associated with a statistically significant decrease in negative symptoms at the 6-month follow-up, reflecting modest clinical improvement. There was no significant effect on positive or general psychopathology symptoms.

[1]  M. Olfson,et al.  Linking inpatients with schizophrenia to outpatient care. , 1998, Psychiatric services.

[2]  A F Lehman,et al.  A randomized trial of assertive community treatment for homeless persons with severe mental illness. , 1997, Archives of general psychiatry.

[3]  C. Beasley,et al.  Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial , 1997, European Neuropsychopharmacology.

[4]  E. Susser,et al.  Preventing recurrent homelessness among mentally ill men: a "critical time" intervention after discharge from a shelter. , 1997, American journal of public health.

[5]  R. Dorwart,et al.  A national study of transitional hospital services in mental health. , 1994, American journal of public health.

[6]  P. Shrout,et al.  Symptom Profiles and Homelessness in Schizophrenia , 1994, The Journal of nervous and mental disease.

[7]  A Labelle,et al.  A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. , 1993, Journal of clinical psychopharmacology.

[8]  N C Andreasen,et al.  Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. , 1992, Archives of general psychiatry.

[9]  J. Brodie,et al.  Negative symptoms and hypofrontality in chronic schizophrenia. , 1992, Archives of general psychiatry.

[10]  A. Fiszbein,et al.  Neurocognitive features of chronic schizophrenic inpatients. , 1991, The Journal of nervous and mental disease.

[11]  W. Carpenter,et al.  Deficit and nondeficit forms of schizophrenia: the concept. , 1988, The American journal of psychiatry.

[12]  Stewart Td,et al.  Alpha blockade and priapism. , 1984 .

[13]  R. Mojtabai,et al.  Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies. , 1998, Schizophrenia bulletin.